SEC Form 4 · accession 0001162194-17-000006

STANDARD BIOTOOLS INC. · LAB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — See Remarks

Period of report

Feb 13, 2017

Accepted (ET)

Feb 15, 2017 · 5:11 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001162194

Table I — non-derivative securities

No Table I lines on this filing.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F1,F2	—	Feb 13, 2017	A	31,600	A	—	—	Common Stock	31,600	31,600	D
Employee Stock Option (Right to Buy)^F3	$6.16	Feb 13, 2017	A	79,300	A	—	Feb 13, 2027	Common Stock	79,300	79,300	D

F1Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
F24/48th of the total number of shares underlying the Restricted Stock Units granted will vest on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.
F31/48th of the total number of shares subject to the option will vest each month after the Vesting Commencement Date, on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that the option will be fully vested on January 1, 2021, subject to recipient continuing to be a Service Provider (as defined in the Fluidigm Corporation 2011 Equity Incentive Plan) through each such date. "Vesting Commencement Date" shall mean January 1, 2017.

SENIOR VP, LEGAL AFFAIRS, GENERAL COUNSEL, CHIEF COMPLIANCE OFFICER AND SECRETARY